Company / Operating Cash Flow per Share
ROCKET PHARMACEUTICALS, INC. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.97
FY2025
5-year range
-$1.97 / -$1.06
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 4 years of decline, reaching $-1.97.
Based on SEC 10-K filings.
-1.97 in FY2025.
Declined from $-1.53 to $-1.97 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 0.2% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.97 | +0.2% |
| FY2024 | -$1.97 | -28.8% |
| FY2023 | -$1.53 | -32.3% |
| FY2022 | -$1.16 | -9.1% |
| FY2021 | -$1.06 | -7.9% |
| FY2020 | -$0.98 | +17.6% |
| FY2019 | -$1.19 | -47.1% |
| FY2018 | -$0.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026